Condition
Advanced Ovarian Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Advanced Ovarian Carcinoma clinical trials that are recruiting, at sites in 7 countries (most in United States (8), Poland (1), Canada (1)). By phase: Phase 1 (3), Phase 2 (3), Phase 3 (1), Early Phase 1 (1). The most active sponsors are M.D. Anderson Cancer Center (2), Mayo Clinic (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 7Countries
Newest Advanced Ovarian Carcinoma clinical trials
All recruiting trials (9)
-
Probiotic support for gut and vaginal microbiome during platinum chemotherapy for advanced or recurrent ovarian cancer
This trial will test whether taking a probiotic during platinum chemotherapy helps keep the gut and vaginal microbiome healthier and may improve symptoms, quality of life, or cancer outcomes for people with advanced or recurrent ovarian cancer.
-
Reducing fatigue in adults with ovarian cancer on PARP inhibitors
This study is testing a tele-health program called REVITALIZE to see if it can help reduce fatigue and improve daily life for adults with ovarian cancer who are taking PARP inhibitors.
-
Using a dendritic cell vaccine to treat advanced ovarian cancer
This study is testing a new vaccine made from patients' own white blood cells to see if it can help people with advanced ovarian cancer live longer and stay cancer-free compared to a placebo.
-
Evaluating NKT3964 for Adults with Advanced Solid Tumors
This study is testing a new drug called NKT3964 to see if it can safely help adults with advanced solid tumors, like ovarian or triple-negative breast cancer, after other treatments have failed.
-
At-home cancer treatment versus clinic-based treatment for advanced cancer patients
This study tests whether giving cancer treatment at home is better for comfort and satisfaction compared to getting it at a clinic for people with advanced cancer.
-
Evaluating OATD-02 for advanced solid tumors
This study is testing a new oral medication called OATD-02 to see if it can help people with advanced solid tumors, like colorectal and ovarian cancer, by making their tumors respond better to treatment.
-
CPI-613 combined with hydroxychloroquine and chemotherapy for advanced solid tumors
This study is testing a new combination of treatments, including CPI-613 and hydroxychloroquine, to see if it can help people with advanced solid tumors that haven't improved with other chemotherapy.
-
Combining Tumor Treating Fields with Cabozantinib or Pembrolizumab and Nab-Paclitaxel for Advanced Solid Tumors
This study is testing a new treatment that combines tumor treating fields with two different cancer drugs to see if it helps people with advanced solid tumors in the abdomen or chest.
-
Minimally invasive surgery for advanced ovarian cancer after chemotherapy
This study is testing if a less invasive surgery is just as effective as traditional surgery for women with advanced ovarian cancer after they have had chemotherapy.
Related topics
Quick answers
How many Advanced Ovarian Carcinoma clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in United States (8 trials), Poland (1 trial), Canada (1 trial), Italy (1 trial), Mexico (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 2: 3, Phase 3: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.